Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06566560
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
The ROAD 20 to Sustainable Medication Use Redispensing Unused Oral Anticancer Drugs
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs
The main questions it aims to answer are
What are the cost-savings of redispensing unused oral anticancer drugs
What is the environmental impact of redispensing unused oral anticancer drugs
Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal
Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital
The main questions it aims to answer are
What are the cost-savings of redispensing unused oral anticancer drugs
What is the environmental impact of redispensing unused oral anticancer drugs
Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal
Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None